Authors: GRES MC JULIAN B BOURRIE M MEUNIER V ROQUES C BERGER M BOULENC X BERGER Y FABRE G

Citation: Mc. Gres et al., CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS, AND APPARENT DRUGPERMEABILITY IN TC-7 CELLS, A HUMAN EPITHELIAL INTESTINAL-CELL LINE -COMPARISON WITH THE PARENTAL CACO-2 CELL-LINE, Pharmaceutical research, 15(5), 1998, pp. 726-733

Authors: BOURRIE M MEUNIER V BERGER Y FABRE G

Citation: M. Bourrie et al., CYTOCHROME-P450 ISOFORM INHIBITORS AS A TOOL FOR THE INVESTIGATION OFMETABOLIC REACTIONS CATALYZED BY HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 321-332

Authors: MEUNIER V BOURRIE M BERGER Y FABRE G

Citation: V. Meunier et al., THE HUMAN INTESTINAL EPITHELIAL-CELL LINE CACO-2 - PHARMACOLOGICAL AND PHARMACOKINETIC APPLICATIONS, Cell biology and toxicology, 11(3-4), 1995, pp. 187-194

Authors: CARO I BOULENC X ROUSSET M MEUNIER V BOURRIE M JULIAN B JOYEUX H ROGUES C BERGER Y ZWEIBAUM A FABRE G

Citation: I. Caro et al., CHARACTERIZATION OF A NEWLY ISOLATED CACO-2 CLONE (TC-7), AS A MODEL OF TRANSPORT PROCESSES AND BIOTRANSFORMATION OF DRUGS, International journal of pharmaceutics, 116(2), 1995, pp. 147-158

Authors: PERRIER L BOURRIE M MARTI E TRONQUET C MASSE D BERGER Y MAGDALOU J FABRE G

Citation: L. Perrier et al., IN-VITRO N-GLUCURONIDATION OF SR-47436 (BMS-186295), A NEW AT1 NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, BY RAT, MONKEY AND HUMAN HEPATIC-MICROSOMAL FRACTIONS, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 91-99